What is cediranib maleate?

Listen to pronunciation. (seh-DEER-uh-nib MAY-lee-AYT) A substance being studied in the treatment of some types of cancer. Cediranib maleate may prevent the growth of new blood vessels that tumors need to grow and may kill cancer cells.

What type of drug is cediranib?

Cediranib is a targeted drug called a cancer growth blocker. Doctors think it can block substances (growth factors) that trigger the cancer cells to divide and grow.

Who makes Cediranib?

Cediranib (AZD-2171; tentative trade name Recentin) is a potent inhibitor of vascular endothelial growth factor (VEGF) receptor tyrosine kinases. The drug is being developed by AstraZeneca as a possible anti-cancer chemotherapeutic agent for oral administration.

What is difference between erlotinib and Gefitinib?

Gefitinib has been approved only for EGFR mutation bearing patients regardless the line of treatment, while erlotinib is also indicated in patients without EGFR mutation who undergo second- or third-line treatment.

What class of drugs is Gefitinib?

Gefitinib is in a class of medications called kinase inhibitors. It works by blocking the action of a certain naturally occurring substance that may be needed to help cancer cells multiply.

What is another name for Avastin?

Bevacizumab is a cancer treatment drug and is also known by its brand name, Avastin. It is a treatment for many different types of cancers.

What are erlotinib and gefitinib?

Gefitinib and erlotinib are the two anti-epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) approved for treatment of advanced NSCLC patients.

Is Avastin chemotherapy or immunotherapy?

Avastin is an immunotherapy drug. Immunotherapy is a treatment that works with your immune system to fight cancer. Avastin works* with your immune system to block a specific protein called vascular endothelial growth factor (VEGF).